Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Orthopedic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.J Clin Oncol. 2005; 23: 2004-2011
- Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).Tumori. 2014; 100: 612-619
- Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?.Eur J Cancer. 2011; 47: 2431-2445
- A meta-analysis of osteosarcoma outcomes in the modern medical era.Sarcoma. 2012; 2012: 704872
Available at: http://nccd.cdc.gov/USCS/childhoodcancerdetailedbyICCC.aspx. Accessed June 17, 2015.
- Conventional osteosarcoma.in: Fletcher C.D.M. Bridge J.A. Hogendoorn P.C.W. WHO classification of tumours of soft tissue and bone. 4th edition. IARC, Lyon (France)2013: 282
- Osteo-sarcoma of the femur and lung.Br Med J. 1877; 2: 921
- Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.Cancer Epidemiol. 2015; 39: 593-599
- Hematogenous micrometastases in osteosarcoma patients.Clin Cancer Res. 2005; 11: 4666-4673
- Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.J Clin Oncol. 2003; 21: 2011-2018
- Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.J Cancer Res Clin Oncol. 1983; 106: 55-67
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.J Clin Oncol. 1987; 5: 21-26
- Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.Cancer. 2012; 118: 5888-5893
- Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.Clin Orthop Relat Res. 1991; 270: 8-14
- The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.N Engl J Med. 1986; 314: 1600-1606
- Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience.Orthopedics. 1985; 8: 659-664
- Effect of concurrent metastatic disease on survival in children and adolescents undergoing lung resection for metastatic osteosarcoma.J Pediatr Surg. 2015; 50: 157-160
- High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.Surg Oncol. 2010; 19: 193-199
- Factors predicting survival following complete surgical remission of pulmonary metastases in osteosarcoma.Mol Clin Oncol. 2015; 3: 157-162
- Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.Eur J Cancer. 2011; 47: 895-902
- Osteosarcoma: the COSS experience.Cancer Treat Res. 2009; 152: 289-308
- Prognostic factors and treatment results of high-grade osteosarcoma in Norway: a scope beyond the “classical” patient.Sarcoma. 2015; 2015: 516843
- Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor.Cancer. 2003; 97: 3068-3075
- Does the histologic subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup.Eur J Cancer. 2002; 38: 1218-1225
- Prognosis of extremity osteosarcoma in patients aged 40-60 years: a cohort/case controlled study at a single institute.Eur J Surg Oncol. 2010; 36: 483-488
- Osteosarcoma in patients older than 65 years.J Clin Oncol. 2008; 26: 5368-5373
- Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.J Cancer Res Clin Oncol. 2010; 136: 561-570
- Paget’s osteosarcoma—no cure in sight.Sarcoma. 1999; 3: 191-192
- Paget’s sarcoma: a historical and outcome review.Clin Orthop Relat Res. 2005; 438: 97-102
- Osteosarcoma treatment–Where do we stand? A state of the art review.Cancer Treat Rev. 2014; 40: 523-532
- Pediatric and adult osteosarcoma: comparisons and contrasts in presentation and therapy.Cancer Treat Rev. 2009; 152: 355-363
- Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.J Clin Oncol. 2013; 31: 2303-2312
- Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials.Med Oncol. 2015; 32: 481
- The role of chemotherapy for metastatic, relapsed, and refractory osteosarcoma.Pediatr Drugs. 2014; 16: 503-512
- EURAMOS-1, an international randomized study for osteosarcoma: results from pre-randomisation treatment.Ann Oncol. 2015; 26: 407-414
- Radiofrequency ablation of metastases from osteosarcoma in patients under 25 years: the SCFE experience.Pediatr Hematol Oncol. 2015; 32: 41-49
- Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.Cancer. 2003; 98: 2447-2456
- Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.J Clin Oncol. 2003; 21: 710-715
- Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.Br J Cancer. 2015; 112: 278-282
- A system for the surgical staging of musculoskeletal sarcoma.Clin Orthop Relat Res. 1980; 153: 103-120
- Hemicortical resection and inlay allograft reconstruction for primary bone tumors: a retrospective evaluation in the Netherlands and review of the literature.J Bone Joint Surg Am. 2015; 97: 738-750
- [F-18]-flurordeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.Cancer. 2009; 115: 3519-3525
- Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.J Nucl Med. 2013; 54: 1053-1059
- Precise resection and biological reconstruction under navigation guidance for young patients with juxta-articular bone sarcoma in lower extremity: preliminary report.J Pediatr Orthop. 2014; 34: 101-108
- Can computer-assisted surgery reduce the risk of an intralesional margin and reduce the rate of local recurrence in patients with a tumour of the pelvis or sacrum?.Bone Joint J. 2013; 95-B: 1417-1424
- Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?.Bone Joint J. 2015; 97-B: 115-120
- Do surgical margins affect local recurrence and survival in extremity, nonmetastatic, high-grade osteosarcoma?.Clin Orthop Relat Res. 2015; ([Epub ahead of print])
- The surgical treatment and outcome of pathological fractures in localised osteosarcoma.J Bone Joint Surg Br. 1996; 78: 694-698
- Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival.Cancer. 1987; 59: 701-709
- Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy.Acta Orthop Scand. 2003; 74: 449-454
- Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities?.Bone Joint J. 2014; 96-B: 1396-1403
- Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: a systemic review and meta-analysis of cohort studies.J Orthop Res. 2015; 33: 131-139
- Surgery for metastatic disease.Curr Opin Pediatr. 2013; 25: 362-367
- Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects.Lancet Oncol. 2010; 11: 670-678
- Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.Cancer. 2014; 120: 3987-3993
- Long-term adverse outcomes in survivors of childhood bone sarcoma: the British Childhood Cancer Survivor Study.Br J Cancer. 2015; 112: 1857-1865
- Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study.BMJ Open. 2012; 2 ([pii:e002197])
- Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival–a report from the Children’s Oncology Group.J Clin Oncol. 2008; 26: 633-638
- Bone sarcomas in pediatrics: progress in our understanding of tumor biology and implications for therapy.Pediatr Drugs. 2015; 17: 257-271
- Translational biology of osteosarcoma.Nat Rev Cancer. 2014; 14: 722-735
Article info
Footnotes
The author has nothing to disclose.
Identification
Copyright
© 2016 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
